Cargando…
WNT5A as a therapeutic target in breast cancer
Despite the clinical development of novel adjuvant and neoadjuvant chemotherapeutic drugs, metastatic breast cancer is one of the leading causes of cancer-related death among women. The present review focuses on the relevance, mechanisms, and therapeutic potential of targeting WNT5A as a future anti...
Autores principales: | Prasad, Chandra Prakash, Manchanda, Mansi, Mohapatra, Purusottam, Andersson, Tommy |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6510844/ https://www.ncbi.nlm.nih.gov/pubmed/30171384 http://dx.doi.org/10.1007/s10555-018-9760-y |
Ejemplares similares
-
Therapy for BRAFi-Resistant Melanomas: Is WNT5A the Answer?
por: Prasad, Chandra Prakash, et al.
Publicado: (2015) -
Demonstration of a WNT5A-IL-6 positive feedback loop in melanoma cells: Dual interference of this loop more effectively impairs melanoma cell invasion
por: Linnskog, Rickard, et al.
Publicado: (2016) -
Combination therapy targeting the elevated interleukin‐6 level reduces invasive migration of BRAF inhibitor‐resistant melanoma cells
por: Mohapatra, Purusottam, et al.
Publicado: (2019) -
Secreted frizzled-related protein 2: a key player in noncanonical Wnt signaling and tumor angiogenesis
por: van Loon, Karlijn, et al.
Publicado: (2020) -
Solute transporters and malignancy: establishing the role of uptake transporters in breast cancer and breast cancer metastasis
por: Sutherland, Rachel, et al.
Publicado: (2020)